Navigation Links
New Data Show In Vitro Potency of Doripenem Against Resistant Bacteria
Date:10/27/2008

WASHINGTON, Oct. 27 /PRNewswire/ -- Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), today announced new study results that demonstrate doripenem (DORIBAX(TM), doripenem for injection), a carbapenem antibiotic, was found to be more potent in vitro against certain strains of Enterobacteriaceae, including Extended-spectrum Beta-lactamases (ESBLs) than other commonly used carbapenems.

Enterobacteriaceae is a large group of bacteria that can cause infections of the digestive tract or other organs of the body and includes common bacteria strains such as E. coli. These new data were presented at the 48th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) / Infectious Diseases Society of America (IDSA) 46th annual meeting in Washington, D.C.

In the study, the incidence and susceptibility of extended-spectrum Beta-lactamase producing Enterobacteriaceae (ESBLE) and ciprofloxacin-resistant Enterobacteriaceae (CIPRE) to doripenem and relevant comparators was evaluated. The data analyzed was pooled from six large, multi-national Phase III clinical trials, including trials that focused on complicated urinary tract infections (cUTIs) and pyelonephritis (2); complicated intra-abdominal infections (cIAI) (2); nosocomial pneumonia (NP), including early-onset ventilator-associated pneumonia (VAP) (1); and VAP, both early- and late-onset (1). The study results showed:

-- Against ESBLE and CIPRE, doripenem was generally more potent in vitro

than imipenem and ertapenem, and inhibited growth of CIPRE and ESBLE at

very low drug concentrations.

-- Doripenem, imipenem and ertapenem, inhibited growth of >90% of ESBLE

at concentrations of 0.25 micrograms/mL, 0.5 micrograms/mL, and 1

micrograms/mL, respectively.

-- Similarly, doripenem, imipenem and ertapenem inhibited the growth of

>90% of CIPRE at concentrations of 0.5 micrograms/mL, 1

m
'/>"/>

SOURCE Johnson & Johnson Pharmaceutical Research & Development,L.L.C.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Georgia Reproductive Specialists Participates in Largest-Ever In Vitro Fertilization Clinical Trial in the World
2. Oritavancin Demonstrates Superior In Vitro Activity to Vancomycin and Metronidazole Against C. Difficile Bacteria
3. Targanta Presents First Data Demonstrating In Vitro Activity and In Vivo Efficacy of Prodrugs in Osteomyelitis Models
4. Oritavancin Demonstrates Potent and Rapid In Vitro Activity Against MRSA, VRE and Other Strains of Resistant Bacteria
5. MatTeks EpiDerm In Vitro Tissues Headed for Validation in Europe
6. Sequoia Pharmaceuticals Presents In Vitro and First-in-Human Data Supporting Further Development of SPI-256, a Novel Investigational Protease Inhibitor
7. Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival
8. New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
9. Vical Begins Phase 1 Trial of DNA Vaccine Against H5N1 Pandemic Influenza
10. Molnlycke Drives Home the Fight Against Staph and Other MRSA Infections
11. Mayo Clinic Study Finds FDA Warning Against Anti-Nausea Drug Droperidol Unnecessary
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... , July 1, 2015 ExeGi Pharma, ... and probiotic treatments, announced today that it has been ... and Non-prescription Health Products Directorate (NNHPD) to sell Visbiome™ ... Visbiome was developed by Professor Claudio De Simone ... extensive clinical investigation. Professor De Simone recently signed an ...
(Date:7/1/2015)... 2015 Boston Scientific Corporation (NYSE: BSX ) ... highlights for the second quarter ended June 30, 2015 on ... The call will be hosted by Mike Mahoney , ... executive vice president and chief financial officer. A ... the Boston Scientific website. Webcast registration is available on the ...
(Date:7/1/2015)... Fla. , July 1, 2015 Rock ... development company focused on chronic inflammatory disease and neurologic ... of principle study with anatabine citrate, the Company,s lead ... oral dose of anatabine citrate can significantly inhibit the ... subjects. The Company is developing this compound in a ...
Breaking Medicine Technology:ExeGi Pharma Secures Canadian Approval For Well Studied Probiotic 2ExeGi Pharma Secures Canadian Approval For Well Studied Probiotic 3Boston Scientific To Webcast Second Quarter 2015 Earnings Call On July 23 2Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 2Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 3Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 4
(Date:7/1/2015)... ... July 01, 2015 , ... Dr. Surya Challa of ... 6th on WAVY-TV’s The Hampton Roads Show to discuss non-invasive CoolSculpting . On ... exercise fall short. , CoolSculpting fat reduction utilizes Cryolipolysis to literally freeze stubborn, ...
(Date:7/1/2015)... ... 01, 2015 , ... During the first week of June, ... and Development) and Chuck Corso (Associate Sales Trainer) participated in the 44th Annual ... together learning and development professionals from more than 300 life sciences companies around ...
(Date:7/1/2015)... ... July 01, 2015 , ... Convoy of Hope will partner with ... Cities on Saturday, August 1, at Spring Lake Park High School. , During the ... $1 million worth of goods and services including free food, health services, family portraits, ...
(Date:7/1/2015)... TEXAS (PRWEB) , ... July 01, 2015 , ... ... and solution provider of IBM software products, announced today that it has received ... for the integration, display and detailed analysis of data from multiple sources providing ...
(Date:7/1/2015)... , ... July 01, 2015 , ... Amada Senior Care, ... new office in the greater Phoenix area – their Mesa, Arizona location . ... senior care with their purchase of the rights to the area after years of ...
Breaking Medicine News(10 mins):Health News:Dr. Surya Challa of Chesapeake Vein Center and MedSpa Will be Featured on The Hampton Roads Show on WAVY-TV 2Health News:Dr. Surya Challa of Chesapeake Vein Center and MedSpa Will be Featured on The Hampton Roads Show on WAVY-TV 3Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 2Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 3Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 4Health News:Convoy of Hope Hosts Community Event in the Twin Cities 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 3Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 4Health News:Amada Senior Care Expands to Greater Phoenix Area 2
... Ten Years of Service, BETHESDA, Md., Dec. 7 ... certain risk factors -- such as parental stress,maternal depression ... a new 10-year study released today by the Family ... who participated in,FSA,s Healthy Families Montgomery program over the ...
... Inverness Medical,Innovations, Inc. (Amex: IMA ), a ... the consumer and professional markets, announced,today that it ... Healthcare,Conference being held December 12, 2007 at The ... Executive Officer, and Jon Russell, Vice,President, Finance, will ...
... and ... Now Even More Heart Benefits, HORSHAM, Pa., ... NutriSystem Advanced, the company,s,breakthrough weight-loss and health and wellness platform. ... a complete,program that includes new proprietary ingredient blends to support ...
... Risks for Obese Youth Increases Urgency for Helping ... Families Make their Holidays ,Heart Healthy, CHICAGO, Dec. ... England Journal of Medicine indicates overweight and obesity in,childhood and ... serious consequences of our nation,s obesity,epidemic are yet to come. ...
... Former CEO Agrees to Forego $420 Million in Compensation ... and Chairman,of UnitedHealth Group Corporation, Dr. William McGuire, today ... that call,for McGuire to return more than $420 million ... to the dating of stock options during,his tenure as ...
... Longs Drugs in ... Honolulu, WALNUT CREEK, Calif., ... announce today that it plans,to lease space to Access Medical Clinics to own ... 2007. The Longs Drugs in,the Mililani Town Center and Ewa Beach will soon ...
Cached Medicine News:Health News:County-Wide Home Visiting Program Found to Reduce Child Abuse and Neglect 2Health News:County-Wide Home Visiting Program Found to Reduce Child Abuse and Neglect 3Health News:Inverness Medical Innovations to Participate at 2007 RBC Healthcare Conference on December 12, 2007 2Health News:NutriSystem 'Advances' Weight-Loss Category 2Health News:NutriSystem 'Advances' Weight-Loss Category 3Health News:YMCA of the USA Offers Simple Tips to Give the Lifetime Gift of Health and Well-Being to Family and Friends This Holiday Season 2Health News:YMCA of the USA Offers Simple Tips to Give the Lifetime Gift of Health and Well-Being to Family and Friends This Holiday Season 3Health News:YMCA of the USA Offers Simple Tips to Give the Lifetime Gift of Health and Well-Being to Family and Friends This Holiday Season 4Health News:Dr. William McGuire Settles with the SEC and the UnitedHealth Group Special Litigation Committee on Stock Options Matter 2Health News:Dr. William McGuire Settles with the SEC and the UnitedHealth Group Special Litigation Committee on Stock Options Matter 3Health News:Longs Drugs Plans to Become the First Retailer in Hawaii With Walk-in Medical Clinics 2Health News:Longs Drugs Plans to Become the First Retailer in Hawaii With Walk-in Medical Clinics 3
The new ProteomeX Workstation enables the rapid set up, execution and analysis of multidimensional LC/MS methods, providing you with the best possible technique to characterize your complex proteomic...
... over a wide range of concentration, ... more thorough characterization than other methods. ... relative change in the distribution of ... to measure heterogeneity, stoichiometry and self-associating ...
Storage temperature: 2 - 8C, linearity: 0 - 700 mg/dL, expected values: 30 - 780 mg/dL. Available with calibrator and number of tests 110....
Intended for the quantitative determination of triglycerides in serum or plasma. Reaction: endpoint, reaction is complete in five minutes at 37C. Wavelength: 540 nm. Linearity: 1000 mg/dL (11.3 mmol/...
Medicine Products: